IL-27–mediated hematopoietic dysregulation exacerbates disease severity in severe fever with thrombocytopenia syndrome virus infection
Science Translational Medicine · 10.06.2026 · 18 (853)
DOI: 10.1126/scitranslmed.adu7243 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Translational Medicine, erschienen am 10.06.2026. Verfasst von Kyeongseok Jeon und 19 weiteren Autor:innen. Beteiligte Einrichtung: Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 03083, Republic of Korea. Hauptthemen laut MEDLINE: Severe Fever with Thrombocytopenia Syndrome, Hematopoiesis, Interleukin-27. Die Arbeit nennt 80 Literaturangaben. Gefördert von: Korea Health Industry Development Institute, National Research Foundation of Korea, National Institute of Health.
Abstract (Originalsprache)
Severe fever with thrombocytopenia syndrome (SFTS) is a life-threatening tick-borne viral infection characterized by high fever, thrombocytopenia, and severe inflammation, with no effective treatments now available. Through comprehensive analysis of bone marrow and peripheral blood mononuclear cells in mice and from patients with SFTS, we identified interleukin-27 (IL-27) as a key driver of disease progression. Elevated IL-27 levels promoted emergency hematopoiesis and impaired protective B cell development and antibody production, resulting in worsened inflammation and ineffective viral control. Inducing IL-27 expression in monocytes and B cells triggered a vicious inflammatory cycle, exacerbating the severity of SFTS. Neutralizing IL-27 in a lethal mouse model of SFTS improved survival, reduced viral loads, and restored antiviral immunity, highlighting IL-27 as a promising therapeutic target for SFTS.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Microbiology and Immunology, Seoul National University College of Medicine, Seoul 03083, Republic of Korea.
- Department of Biomedical Sciences, Seoul National University College of Medicine, Seoul 03080, Republic of Korea.
- Institute of Endemic Disease, Seoul National University Medical Research Center, Seoul 03080, Republic of Korea.
- Department of Microbiology, Soon Chun Hyang University College of Medicine, Cheonan, Chungcheongnam-do 33151, Republic of Korea.
- Translational Immunology Institute, Chungnam National University, Daejeon 35015, Republic of Korea.
- Korea Zoonosis Research Institute, Jeonbuk National University, Iksan 54531, Republic of Korea.
ORCID-Profile: Kyeongseok Jeon, Hyo-Jin Ro, Joowan Kim, Yebeen Lee, Uni Park, Yuri Kim, Yu-Jin Kim, Na-Young Ha, Yejin Choi, Da-Jeong Park, Cheol-Heui Yun, Yoon Hwan Chang, Yoon Kyung Jeon, Young Ki Choi, Jae U Jung, Dong-Min Kim, Yeon-Sook Kim, Nam-Hyuk Cho
Förderung
- Korea Health Industry Development Institute
- National Research Foundation of Korea
- National Institute of Health
Zitieren
APA
Jeon, K., Ro, H. J., Kim, J., Lee, Y., Park, U., Kim, Y., Kim, Y. J., Ha, N. Y., Jeong, D. E., Choi, Y., Park, D. J., Yun, C. H., Kang, J. G., Chang, Y. H., Jeon, Y. K., Choi, Y. K., Jung, J. U., Kim, D. M., Kim, Y. S., & Cho, N. H. (2026). IL-27–mediated hematopoietic dysregulation exacerbates disease severity in severe fever with thrombocytopenia syndrome virus infection. Science Translational Medicine, 18(853). https://doi.org/10.1126/scitranslmed.adu7243
Vancouver
Jeon K, Ro HJ, Kim J, Lee Y, Park U, Kim Y, et al. IL-27–mediated hematopoietic dysregulation exacerbates disease severity in severe fever with thrombocytopenia syndrome virus infection. Science Translational Medicine. 2026;18(853). doi:10.1126/scitranslmed.adu7243
BibTeX
@article{Jeon2026,
author = {Jeon, Kyeongseok and Ro, Hyo-Jin and Kim, Joowan and Lee, Yebeen and Park, Uni and Kim, Yuri and Kim, Yu-Jin and Ha, Na-Young and Jeong, Da-Eun and Choi, Yejin and Park, Da-Jeong and Yun, Cheol-Heui and Kang, Jun-Gu and Chang, Yoon Hwan and Jeon, Yoon Kyung and Choi, Young Ki and Jung, Jae U and Kim, Dong-Min and Kim, Yeon-Sook and Cho, Nam-Hyuk},
title = {IL-27–mediated hematopoietic dysregulation exacerbates disease severity in severe fever with thrombocytopenia syndrome virus infection},
journal = {Science Translational Medicine},
year = {2026},
volume = {18},
number = {853},
doi = {10.1126/scitranslmed.adu7243}
}
EUVIMED